The CWR22Rv1 prostate cancer cell line expresses AR full-length (AR(FL)) with a duplicated DBD in exon 317, 18, 19 and an AR splice variant, AR(V), lacking a LBD, thus becoming constitutively active4, 8, 11, 20. Here, AR is linked to prostate cancer.